Cargando…
Chyluria: what does the clinician need to know?
Chyluria is secondary to the presence of chyle in the urine. The classical appearance on inspection is of milky white urine, which is caused by a fistulous communication between the lymphatic system and the urinary tract. Worldwide, it is most commonly associated with the parasite Wuchereria bancrof...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366404/ https://www.ncbi.nlm.nih.gov/pubmed/32728391 http://dx.doi.org/10.1177/1756287220940899 |
_version_ | 1783560213500002304 |
---|---|
author | Stainer, Victoria Jones, Patrick Juliebø, Siri Øvereng Beck, Rupert Hawary, Amr |
author_facet | Stainer, Victoria Jones, Patrick Juliebø, Siri Øvereng Beck, Rupert Hawary, Amr |
author_sort | Stainer, Victoria |
collection | PubMed |
description | Chyluria is secondary to the presence of chyle in the urine. The classical appearance on inspection is of milky white urine, which is caused by a fistulous communication between the lymphatic system and the urinary tract. Worldwide, it is most commonly associated with the parasite Wuchereria bancrofti, which is prevalent in Asia, most extensively in India but also China and Taiwan. However, in the United Kingdom, Europe and North America, where the condition is rare, non-parasitic aetiologies predominate. Chyluria is occasionally associated with other urinary tract symptoms including infection, loin pain and haematuria. It may also cause hypoproteinaemia, weight loss and cachexia. Management is based on identifying the aetiology and depends on the severity of the chyluria and presence of associated symptoms. Given its predominate symptom being urinary, cases in the West can fall under the care of the urologist. The aim of this article is to provide an overview and summary of the aetiology, assessment and management of chyluria based on the most up-to-date evidence available. This was achieved through a non-systematic review of world literature. |
format | Online Article Text |
id | pubmed-7366404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-73664042020-07-28 Chyluria: what does the clinician need to know? Stainer, Victoria Jones, Patrick Juliebø, Siri Øvereng Beck, Rupert Hawary, Amr Ther Adv Urol Review Chyluria is secondary to the presence of chyle in the urine. The classical appearance on inspection is of milky white urine, which is caused by a fistulous communication between the lymphatic system and the urinary tract. Worldwide, it is most commonly associated with the parasite Wuchereria bancrofti, which is prevalent in Asia, most extensively in India but also China and Taiwan. However, in the United Kingdom, Europe and North America, where the condition is rare, non-parasitic aetiologies predominate. Chyluria is occasionally associated with other urinary tract symptoms including infection, loin pain and haematuria. It may also cause hypoproteinaemia, weight loss and cachexia. Management is based on identifying the aetiology and depends on the severity of the chyluria and presence of associated symptoms. Given its predominate symptom being urinary, cases in the West can fall under the care of the urologist. The aim of this article is to provide an overview and summary of the aetiology, assessment and management of chyluria based on the most up-to-date evidence available. This was achieved through a non-systematic review of world literature. SAGE Publications 2020-07-16 /pmc/articles/PMC7366404/ /pubmed/32728391 http://dx.doi.org/10.1177/1756287220940899 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Stainer, Victoria Jones, Patrick Juliebø, Siri Øvereng Beck, Rupert Hawary, Amr Chyluria: what does the clinician need to know? |
title | Chyluria: what does the clinician need to know? |
title_full | Chyluria: what does the clinician need to know? |
title_fullStr | Chyluria: what does the clinician need to know? |
title_full_unstemmed | Chyluria: what does the clinician need to know? |
title_short | Chyluria: what does the clinician need to know? |
title_sort | chyluria: what does the clinician need to know? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366404/ https://www.ncbi.nlm.nih.gov/pubmed/32728391 http://dx.doi.org/10.1177/1756287220940899 |
work_keys_str_mv | AT stainervictoria chyluriawhatdoestheclinicianneedtoknow AT jonespatrick chyluriawhatdoestheclinicianneedtoknow AT juliebøsiriøvereng chyluriawhatdoestheclinicianneedtoknow AT beckrupert chyluriawhatdoestheclinicianneedtoknow AT hawaryamr chyluriawhatdoestheclinicianneedtoknow |